# Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome

> **NCT07698626** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Bladder Pain Syndrome
- Chronic Pelvic Nociplastic Pain
- Interstitial Cystitis

## Interventions

- **DRUG:** Venlafaxine oral tablet combined with Education and Behavioral Modification Program (EBMP)
- **BEHAVIORAL:** Education and Behavioral Modification Program (EBMP) only

## Key facts

- **NCT ID:** NCT07698626
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-31
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698626, "Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*